drugset / Trial / NCT04811326
Latanoprost Plus NB-UVB Versus Each Alone in Non-segmental Vitiligo: Clinical and Laboratory Evaluation
RandomizedFactorialSingle-blindTreatment
Summary
The aim of the study is to evaluate the efficacy of different lines of therapies on the TWEAK serum level in patients with non-segmental vitiligo.
Timeline
- Start
- 2021-01-13
- Primary completion
- 2024-02-13
- Completion
- 2024-03-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Latanoprost | Small molecule | 0.005 % | Topical |